Pneumococcal purified capsular polysaccharides - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
PREVENAR 13 pneumococcal polysaccharide conjugate vaccine 13 valent adsorbed 0.5 mL syringe AUST R: 158450Active ingredients:
Pneumococcal purified capsular polysaccharides
Dosage form:
Injection, suspension
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800675229
|
Deletion from market:
30 Jun 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
This product will be replaced by Prevenar 20 pneumococcal polysaccharide conjugate vaccine (ARTG 376353)
|